Literature DB >> 2591222

Hemodynamic responses to amiodarone in critically ill patients receiving catecholamine infusions.

A W Holt1.   

Abstract

The hemodynamic response after an iv loading dose of amiodarone for resistant supraventricular tachyarrhythmias was studied in ten critically ill patients receiving a catecholamine infusion for shock. A loading dose of amiodarone, 3.7 to 5.0 mg/kg, was infused over 2 h while the catecholamine infusion dose requirements were monitored. There was a significant decrease in heart rate (mean 16%, p less than .01), and an increase in stroke volume index (mean 29%, p less than .01) and left ventricular stroke work index (mean 34%, p less than .01). Cardiac index, oxygen availability index, and mean arterial pressure were not changed significantly. The reported adrenoreceptor antagonism of amiodarone did not change catecholamine dose requirements in this study. In nine of ten patients, sinus rhythm was achieved and maintained. The loading dose of amiodarone had no significant acute effect on plasma digoxin concentrations. Despite good arrhythmia control, mortality was high.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2591222     DOI: 10.1097/00003246-198912000-00006

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  6 in total

1.  Acute amiodarone-induced lung toxicity.

Authors:  L Donaldson; I S Grant; M R Naysmith; J S Thomas
Journal:  Intensive Care Med       Date:  1998-06       Impact factor: 17.440

2.  Acute hemodynamic effects of intravenous amiodarone treatment in paediatric cardiac surgical patients.

Authors:  Nikolaus A Haas; Christoph K Camphausen
Journal:  Clin Res Cardiol       Date:  2008-06-05       Impact factor: 5.460

Review 3.  Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias.

Authors:  J Gill; R C Heel; A Fitton
Journal:  Drugs       Date:  1992-01       Impact factor: 9.546

4.  Management of atrial tachyarrhythmias in the critically ill: a comparison of intravenous procainamide and amiodarone.

Authors:  M J Chapman; J L Moran; M S O'Fathartaigh; A R Peisach; D N Cunningham
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

Review 5.  Clinical review: treatment of new-onset atrial fibrillation in medical intensive care patients--a clinical framework.

Authors:  Mengalvio E Sleeswijk; Trudeke Van Noord; Jaap E Tulleken; Jack J M Ligtenberg; Armand R J Girbes; Jan G Zijlstra
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

6.  Variable use of amiodarone is associated with a greater risk of recurrence of atrial fibrillation in the critically ill.

Authors:  Goran Mitrić; Andrew Udy; Hiran Bandeshe; Pierre Clement; Rob Boots
Journal:  Crit Care       Date:  2016-04-02       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.